Filter (Type enter to validate)
  Cat_Number Product name Supplier Quantity Price Tech More
UT801 Endometrial disease spectrum (endometrial cancer progression) tissue array, 80 cases 80 cores US Biomax 278 UT801 Endometrial disease spectrum (endometrial cancer progression) tissue array, 80 cases 80 cores US Biomax 278
ASK
Publication
UT1001 Endometrial cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 266 UT1001 Endometrial cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 266
ASK
Publication
T091 Endometrial cancer test tissue array, with normal endometriual tissue as control, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 T091 Endometrial cancer test tissue array, with normal endometriual tissue as control, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88
ASK
Publication
T093 Uterus cancer test tissue array, with normal endometrial tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 T093 Uterus cancer test tissue array, with normal endometrial tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88
ASK
Publication
CSB-EL002712CA Cat bladder cancer associated protein (BLCAP) ELISA kit, Species Cat, Sample Type serum, plasma Cusabio 96T 913 CSB-EL002712CA Cat bladder cancer associated protein (BLCAP) ELISA kit, Species Cat, Sample Type serum, plasma Cusabio 96T 913
ASK
Publication
EMC1021 Endometrial cancer tissue array, 102 caese 102 cores US Biomax 225 EMC1021 Endometrial cancer tissue array, 102 caese 102 cores US Biomax 225
ASK
Publication
AA0037 Nuclear Membrane Receptors Phospho-Specific Array includes 52 highly specific and well-characterized phosphorylation antibodies related to Nuclear Membrane Receptors. Abnova 2 Pieces/Box 731 AA0037 Nuclear Membrane Receptors Phospho-Specific Array includes 52 highly specific and well-characterized phosphorylation antibodies related to Nuclear Membrane Receptors. Abnova 2 Pieces/Box 731
ASK
Publication
MC245 Multiple cancer (12 type) and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing MC242 US Biomax 88 MC245 Multiple cancer (12 type) and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing MC242 US Biomax 88
ASK
Publication
EMC1501 Endometrial cancer mid density tissue array, non overlapping with EMC1502, 75 cases 150 cores US Biomax 225 EMC1501 Endometrial cancer mid density tissue array, non overlapping with EMC1502, 75 cases 150 cores US Biomax 225
ASK
Publication
EMC1502 Endometrial cancer mid density tissue array, non overlapping with EMC1501, 75 caese 150 cores US Biomax 225 EMC1502 Endometrial cancer mid density tissue array, non overlapping with EMC1501, 75 caese 150 cores US Biomax 225
ASK
Publication
EMC961 Endometrial cancer and normal tissue array, non overlapping with EMC962, 48 cases 96 cores US Biomax 225 EMC961 Endometrial cancer and normal tissue array, non overlapping with EMC962, 48 cases 96 cores US Biomax 225
ASK
Publication
EMC962 Endometrial cancer and normal tissue array, non overlapping with EMC961 48 cases 96 cores US Biomax 225 EMC962 Endometrial cancer and normal tissue array, non overlapping with EMC961 48 cases 96 cores US Biomax 225
ASK
Publication
UT241 Uterine endometrial cancer tissue array with normal tissue from autopsy, 12 cases 24 cores, with TNM data US Biomax 100 UT241 Uterine endometrial cancer tissue array with normal tissue from autopsy, 12 cases 24 cores, with TNM data US Biomax 100
ASK
Publication
CSB-EL020656RH Monkey serum amyloid A1 (SAA1) ELISA kit, Species Monkey, Sample Type serum, plasma Cusabio 96T 913 CSB-EL020656RH Monkey serum amyloid A1 (SAA1) ELISA kit, Species Monkey, Sample Type serum, plasma Cusabio 96T 913 Publication
ICTS-SER Cancer samples: Colorectal Cancer Serum-Adenocarcinoma Innovative Research INC Each 266 ICTS-SER Cancer samples: Colorectal Cancer Serum-Adenocarcinoma Innovative Research INC Each 266
ASK
Publication
IBSC-SER Cancer samples: Breast Cancer Serum Innovative Research INC Each 266 IBSC-SER Cancer samples: Breast Cancer Serum Innovative Research INC Each 266
ASK
Publication
IOVC-SER Cancer samples: Ovarian Cancer Serum Innovative Research INC Each 266 IOVC-SER Cancer samples: Ovarian Cancer Serum Innovative Research INC Each 266
ASK
Publication
CSB-E15075r Rat Forkhead Box P3(FOXP3) ELISA Kit, Species Rat, Sample Type serum, plasma Cusabio 96T 913.5 CSB-E15075r Rat Forkhead Box P3(FOXP3) ELISA Kit, Species Rat, Sample Type serum, plasma Cusabio 96T 913.5
ASK
Publication
CSB-E13995p Pig thrombin-antithrombin complex,TAT ELISA Kit, Species Pig, Sample Type serum, plasma Cusabio 96T 959.7 CSB-E13995p Pig thrombin-antithrombin complex,TAT ELISA Kit, Species Pig, Sample Type serum, plasma Cusabio 96T 959.7
ASK
Publication
CSB-EL005599RA Rat Mast Cell Chymase ELISA Kit, Species Rat, Sample Type serum, plasma Cusabio 96T 808.5 CSB-EL005599RA Rat Mast Cell Chymase ELISA Kit, Species Rat, Sample Type serum, plasma Cusabio 96T 808.5
ASK
Publication
IHKDC-SER Cancer samples: Kidney Carcinoma Serum Innovative Research INC Each 266 IHKDC-SER Cancer samples: Kidney Carcinoma Serum Innovative Research INC Each 266
ASK
Publication
ILVRC-SER Cancer samples: Liver Carcinoma Serum Innovative Research INC Each 313 ILVRC-SER Cancer samples: Liver Carcinoma Serum Innovative Research INC Each 313
ASK
Publication
IMLNM-SER Cancer samples: Melanoma Patient Serum Innovative Research INC Each 302 IMLNM-SER Cancer samples: Melanoma Patient Serum Innovative Research INC Each 302
ASK
Publication
IPSTC-SER Cancer samples: Prostate Carcinoma Serum Innovative Research INC Each 266 IPSTC-SER Cancer samples: Prostate Carcinoma Serum Innovative Research INC Each 266
ASK
Publication
IRCTC-SER Cancer samples: Rectum Adenocarcinoma Serum Innovative Research INC Each 266 IRCTC-SER Cancer samples: Rectum Adenocarcinoma Serum Innovative Research INC Each 266
ASK
Publication
ITHYC-SER Cancer samples: Thyroid Carcinoma Serum Innovative Research INC Each 302 ITHYC-SER Cancer samples: Thyroid Carcinoma Serum Innovative Research INC Each 302
ASK
Publication
ITSTC-SER Cancer samples: Testis Carcinoma Serum Innovative Research INC Each 302 ITSTC-SER Cancer samples: Testis Carcinoma Serum Innovative Research INC Each 302
ASK
Publication
1C05C1 PSA test card, serum , Cancer markers Bosbio 500 tests 620 1C05C1 PSA test card, serum , Cancer markers Bosbio 500 tests 620 Publication
ICVXC-SER Cancer samples: Cervix Carcinoma Human Serum Innovative Research INC Each 302 ICVXC-SER Cancer samples: Cervix Carcinoma Human Serum Innovative Research INC Each 302
ASK
Publication
IHDNK-SER Cancer samples: Head and Neck Carcinoma Serum Innovative Research INC Each 302 IHDNK-SER Cancer samples: Head and Neck Carcinoma Serum Innovative Research INC Each 302
ASK
Publication
ILNGC-SER Cancer samples: Lung Carcinoma (NSCLC) Serum Innovative Research INC Each 266 ILNGC-SER Cancer samples: Lung Carcinoma (NSCLC) Serum Innovative Research INC Each 266
ASK
Publication
OV1501 Ovarian cancer tissue array, with TNM, clinical stage and pathology grade, 75 cases 150 cores US Biomax 231 OV1501 Ovarian cancer tissue array, with TNM, clinical stage and pathology grade, 75 cases 150 cores US Biomax 231
ASK
Publication
CO485 Colon cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores US Biomax 231 CO485 Colon cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores US Biomax 231
ASK
Publication
FMC407 Multiple organ cancer frozen tissue array, including TNM and clinical stage, 40 cases 40 cores US Biomax 331 FMC407 Multiple organ cancer frozen tissue array, including TNM and clinical stage, 40 cases 40 cores US Biomax 331
ASK
Publication
FMC408 Multiple organ cancer frozen tissue array, including TNM and clinical stage, 40 cases 40 cores US Biomax 167 FMC408 Multiple organ cancer frozen tissue array, including TNM and clinical stage, 40 cases 40 cores US Biomax 167
ASK
Publication
LV1002 Liver cancer tissue array, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 231 LV1002 Liver cancer tissue array, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 231
ASK
Publication
LV484 Liver cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores US Biomax 231 LV484 Liver cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores US Biomax 231
ASK
Publication
OV484 Ovarian cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores US Biomax 231 OV484 Ovarian cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores US Biomax 231
ASK
Publication
TH721 Thyroid cancer and normal tissue array with clinical stage and grade info, 24 cases 72 cores US Biomax 266 TH721 Thyroid cancer and normal tissue array with clinical stage and grade info, 24 cases 72 cores US Biomax 266
ASK
Publication
BC051110 Colon cancer and normal tissue array, including TNM, clinical stage and pathology grade, 120 cases 120 cores US Biomax 278 BC051110 Colon cancer and normal tissue array, including TNM, clinical stage and pathology grade, 120 cases 120 cores US Biomax 278
ASK
Publication
BC051111 Colon cancer and normal tissue array, including TNM, clinical stage and pathology grade, 100 cases 200 cores US Biomax 456 BC051111 Colon cancer and normal tissue array, including TNM, clinical stage and pathology grade, 100 cases 200 cores US Biomax 456
ASK
Publication
CO20810 Colon cancer survey tissue array (5 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 CO20810 Colon cancer survey tissue array (5 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
CO2087 Colon cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 CO2087 Colon cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
CO2088 Colon cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 CO2088 Colon cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
CO2089 Colon cancer survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 CO2089 Colon cancer survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
CR2084 Cervical cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 CR2084 Cervical cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
CR2085 Cervix cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 CR2085 Cervix cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
KD2085 Kidney cancer survey tissue array (1 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 KD2085 Kidney cancer survey tissue array (1 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
KD2086 Kidney cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 KD2086 Kidney cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
KD2087 Kidney cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 KD2087 Kidney cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
KD2088 Kidney cancer survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 KD2088 Kidney cancer survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
LC20810 Lung cancer survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 LC20810 Lung cancer survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
LC20811 Lung cancer survey tissue array (5 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 LC20811 Lung cancer survey tissue array (5 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
LC2088 Lung cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 LC2088 Lung cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
LC2089 Lung cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 LC2089 Lung cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
LV1001 Liver cancer antibody screening array, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 231 LV1001 Liver cancer antibody screening array, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 231
ASK
Publication
LV2084 Liver cancer survey tissue array (1 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 516 LV2084 Liver cancer survey tissue array (1 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 516
ASK
Publication
LV2085 Liver cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 LV2085 Liver cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
LV2086 Liver cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 LV2086 Liver cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
LV2087 Liver cancer survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 LV2087 Liver cancer survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
LV2088 Liver cancer survey tissue array (5 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 LV2088 Liver cancer survey tissue array (5 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
MC601 Multi organ cancer tissue array, including TNM, clinical stage and pathology grade, 60 cases 60 cores US Biomax 231 MC601 Multi organ cancer tissue array, including TNM, clinical stage and pathology grade, 60 cases 60 cores US Biomax 231
ASK
Publication
OV2085 Ovary cancer survey tissue array (1 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 OV2085 Ovary cancer survey tissue array (1 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
OV2086 Ovary cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 OV2086 Ovary cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
OV2087 Ovary cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 OV2087 Ovary cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
OV2088 Ovary cancer survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 OV2088 Ovary cancer survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
OV2089 Ovary cancer survey tissue array (5 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 OV2089 Ovary cancer survey tissue array (5 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
PA961 Pancreatic cancer and normal tissue array, including TNM, clinical stage and pathology grade, 96 cases 96 cores US Biomax 278 PA961 Pancreatic cancer and normal tissue array, including TNM, clinical stage and pathology grade, 96 cases 96 cores US Biomax 278
ASK
Publication
RE601 Colon and rectum cancer tissue array, including TNM, clinical stage and pathology grade, 60 cases 60 cores US Biomax 231 RE601 Colon and rectum cancer tissue array, including TNM, clinical stage and pathology grade, 60 cases 60 cores US Biomax 231
ASK
Publication
CSB-EL024054PI Pig translocase of outer mitochondrial membrane 7 homolog (yeast) (TOMM7) ELISA kit, Species Pig, Sample Type serum, plasma Cusabio 96T 887 CSB-EL024054PI Pig translocase of outer mitochondrial membrane 7 homolog (yeast) (TOMM7) ELISA kit, Species Pig, Sample Type serum, plasma Cusabio 96T 887 Publication
24012 Primary antibody DR3 Antibody, Source Rabbit, Species Reactivity No cross reaction to other death receptors. SignalWay Antibody S.A.B 100ug 364 24012 Primary antibody DR3 Antibody, Source Rabbit, Species Reactivity No cross reaction to other death receptors. SignalWay Antibody S.A.B 100ug 364
ASK
Publication
24032 Primary antibody DR3 Antibody, Source Rabbit, Species Reactivity DR3 has no cross reaction to other death receptors. SignalWay Antibody S.A.B 100ug 364 24032 Primary antibody DR3 Antibody, Source Rabbit, Species Reactivity DR3 has no cross reaction to other death receptors. SignalWay Antibody S.A.B 100ug 364
ASK
Publication
BL1001 Bladder cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 266 BL1001 Bladder cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 266
ASK
Publication
BR1003 Breast pre cancerous disease and cancer tissue array (100 cases 101 cores), with clinical stage and pathology grade data US Biomax 266 BR1003 Breast pre cancerous disease and cancer tissue array (100 cases 101 cores), with clinical stage and pathology grade data US Biomax 266
ASK
Publication
BR1007 Breast cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 266 BR1007 Breast cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 266
ASK
Publication
BR246 Breast cancer tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by BR246a US Biomax 88 BR246 Breast cancer tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by BR246a US Biomax 88
ASK
Publication
CO486 Colon cancer tissue array, including TNM, clinical stage and pathology grade, 2 serial sections, 48 cases 96 cores US Biomax 397 CO486 Colon cancer tissue array, including TNM, clinical stage and pathology grade, 2 serial sections, 48 cases 96 cores US Biomax 397
ASK
Publication
CR1003 Cervix cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 231 CR1003 Cervix cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 231
ASK
Publication
ES1001 Esophagus cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 266 ES1001 Esophagus cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 266
ASK
Publication
ES1002 Esophageal cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 266 ES1002 Esophageal cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 266
ASK
Publication
KD1001 Kidney cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 231 KD1001 Kidney cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 231
ASK
Publication
KD1002 Kidney cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 231 KD1002 Kidney cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 231
ASK
Publication
LV485 Liver cancer tissue array, including TNM, clinical stage and pathology grade, 2 serial sections, 48 cases 96 cores US Biomax 397 LV485 Liver cancer tissue array, including TNM, clinical stage and pathology grade, 2 serial sections, 48 cases 96 cores US Biomax 397
ASK
Publication
OV1003 Ovarian cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 231 OV1003 Ovarian cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 231
ASK
Publication
OV1004 Ovarian cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 231 OV1004 Ovarian cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 231
ASK
Publication
OV485 Ovarian cancer tissue array, including TNM, clinical stage and pathology grade, 2 serial sections, 48 cases 96 cores US Biomax 397 OV485 Ovarian cancer tissue array, including TNM, clinical stage and pathology grade, 2 serial sections, 48 cases 96 cores US Biomax 397
ASK
Publication
ST1003 Stomach cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 231 ST1003 Stomach cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 231
ASK
Publication
BC05118 Colon cancer and matched adjacent normal tissue array, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 266 BC05118 Colon cancer and matched adjacent normal tissue array, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 266
ASK
Publication
BL1501 Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258 BL1501 Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
BR2086 Breast cancer and normal tissue array, including TNM, clinical stage and pathology grade, 208 cases 208 cores, replacing BR2001 US Biomax 456 BR2086 Breast cancer and normal tissue array, including TNM, clinical stage and pathology grade, 208 cases 208 cores, replacing BR2001 US Biomax 456
ASK
Publication
BR8014 Breast cancer and normal tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores, replacing BR8012 US Biomax 231 BR8014 Breast cancer and normal tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores, replacing BR8012 US Biomax 231
ASK
Publication
BR964 Breast cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 228 BR964 Breast cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 228
ASK
Publication
CO1021 Colon cancer tissue array, including TNM, clinical stage and pathology grade, 102 cases 102 cores; ihc Anti-Actin confirmed US Biomax 296 CO1021 Colon cancer tissue array, including TNM, clinical stage and pathology grade, 102 cases 102 cores; ihc Anti-Actin confirmed US Biomax 296
ASK
Publication
CO1502 Colon cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258 CO1502 Colon cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
CO962 Colon cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 258 CO962 Colon cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
CR1501 Cervical cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258 CR1501 Cervical cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
EN801a Endocrine cancer tissue array, including TNM and clinical stage, 40 cases 80 cores, replacing EN801; ihc Anti-Actin confirmed US Biomax 296 EN801a Endocrine cancer tissue array, including TNM and clinical stage, 40 cases 80 cores, replacing EN801; ihc Anti-Actin confirmed US Biomax 296
ASK
Publication
ES1502 Esophageal cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258 ES1502 Esophageal cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
KD1501 Kidney cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258 KD1501 Kidney cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
LC1502 Lung cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258 LC1502 Lung cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
LC961 Lung cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 258 LC961 Lung cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
LV1502 Liver cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258 LV1502 Liver cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
LV6161 High density liver cancer array, with clinical stage, pathology grade and normal hepatic tissue, 322 cases 616 cores US Biomax 753 LV6161 High density liver cancer array, with clinical stage, pathology grade and normal hepatic tissue, 322 cases 616 cores US Biomax 753
ASK
Publication
LV962 Liver cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 258 LV962 Liver cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
PR484 Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 24 cases 48 cores; ihc Anti-Actin confirmed US Biomax 162 PR484 Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 24 cases 48 cores; ihc Anti-Actin confirmed US Biomax 162
ASK
Publication
RE1021 Rectum cancer tissue array, including TNM, clinical stage and pathology grade, 102 cases 102 cores; ihc Anti-Actin confirmed US Biomax 296 RE1021 Rectum cancer tissue array, including TNM, clinical stage and pathology grade, 102 cases 102 cores; ihc Anti-Actin confirmed US Biomax 296
ASK
Publication
RE1503 Rectum cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258 RE1503 Rectum cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
ST812 Stomach cancer tissue array with normal tissues from autopsy, with clinical stage (TNM) and pathology grade info, 40 cases 80 cores US Biomax 231 ST812 Stomach cancer tissue array with normal tissues from autopsy, with clinical stage (TNM) and pathology grade info, 40 cases 80 cores US Biomax 231
ASK
Publication
ST962 Stomach cancer tissue array, including clinical stage, TNM and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 228 ST962 Stomach cancer tissue array, including clinical stage, TNM and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 228
ASK
Publication
T104 Cervical cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 T104 Cervical cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
T125 Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 T125 Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
T144 Pancreas cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 T144 Pancreas cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
UT1501 Uterus cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258 UT1501 Uterus cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
UT961 Endometrium cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 228 UT961 Endometrium cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 228
ASK
Publication
MC241 Multiple cancer (12 type) tissue array, 12 cases 24 cores, replaced by MC244 US Biomax 88 MC241 Multiple cancer (12 type) tissue array, 12 cases 24 cores, replaced by MC244 US Biomax 88
ASK
Publication
MC242 Multiple cancer (12 type) tissue array, 16 cases 24 cores, replaced by MC245 US Biomax 88 MC242 Multiple cancer (12 type) tissue array, 16 cases 24 cores, replaced by MC245 US Biomax 88
ASK
Publication
FMC406c Frozen multiple human organ cancer tissue array, including TNM and clinical stage, 40 cases 40 cores; ihc Anti-Actin confirmed US Biomax 626 FMC406c Frozen multiple human organ cancer tissue array, including TNM and clinical stage, 40 cases 40 cores; ihc Anti-Actin confirmed US Biomax 626
ASK
Publication
OV2084 Ovarian cancer tissue array with normal adjacent ovary, TNM, clinical stage and pathology grade, 208 cases 208 cores, replaced by OV20814 US Biomax 456 OV2084 Ovarian cancer tissue array with normal adjacent ovary, TNM, clinical stage and pathology grade, 208 cases 208 cores, replaced by OV20814 US Biomax 456
ASK
Publication
T071 Kidney cancer test tissue array, with normal renal tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 T071 Kidney cancer test tissue array, with normal renal tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88
ASK
Publication
T343 Head & Neck cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 T343 Head & Neck cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
T461 Thymus cancer test tissue array, with normal control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 T461 Thymus cancer test tissue array, with normal control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88
ASK
Publication
TH802a Thyroid cancer and adenoma tissue array, including TNM and clinical stage, 80 cases 80 cores, replacing TH802; ihc Anti-Actin confirmed US Biomax 267 TH802a Thyroid cancer and adenoma tissue array, including TNM and clinical stage, 80 cases 80 cores, replacing TH802; ihc Anti-Actin confirmed US Biomax 267
ASK
Publication
CSB-E06971Rb rabbit Leptin,LEP ELISA Kit, Species rabbit, Sample Type serum, plasma Cusabio 96T 503 CSB-E06971Rb rabbit Leptin,LEP ELISA Kit, Species rabbit, Sample Type serum, plasma Cusabio 96T 503 Publication
CSB-E14005B Bovine Androstenedione,ASD ELISA Kit, Species Bovine, Sample Type serum, plasma Cusabio 96T 940 CSB-E14005B Bovine Androstenedione,ASD ELISA Kit, Species Bovine, Sample Type serum, plasma Cusabio 96T 940 Publication
CSB-E14116Fh Grouper Vitellogenin,VTG ELISA Kit, Species Grouper, Sample Type serum, plasma Cusabio 96T 915 CSB-E14116Fh Grouper Vitellogenin,VTG ELISA Kit, Species Grouper, Sample Type serum, plasma Cusabio 96T 915
ASK
Publication
CSB-E15088h Human apolipoprotein A4 (Apo-A4) ELISA Kit, Species Human, Sample Type serum, plasma Cusabio 96T 798 CSB-E15088h Human apolipoprotein A4 (Apo-A4) ELISA Kit, Species Human, Sample Type serum, plasma Cusabio 96T 798
ASK
Publication
CSB-E14211h Human interleukin 2(IL-2) antibody ELISA Kit, Species Human, Sample Type serum, plasma Cusabio 96T 913 CSB-E14211h Human interleukin 2(IL-2) antibody ELISA Kit, Species Human, Sample Type serum, plasma Cusabio 96T 913
ASK
Publication
CSB-E15791Fh Fish Luteinizing Hormone(LH)ELISA Kit, Species Fish, Sample Type serum, plasma Cusabio 96T 688 CSB-E15791Fh Fish Luteinizing Hormone(LH)ELISA Kit, Species Fish, Sample Type serum, plasma Cusabio 96T 688 Publication
MC482 Multiple cancer (12 type) tissue microarray, 40 cases 48 cores, with stage and grade information US Biomax 160 MC482 Multiple cancer (12 type) tissue microarray, 40 cases 48 cores, with stage and grade information US Biomax 160
ASK
Publication
CSB-E05032h Human Legionella pneumophila antigen,LP Ag ELISA Kit, Species Human, Sample Type serum, plasma Cusabio 96T 981 CSB-E05032h Human Legionella pneumophila antigen,LP Ag ELISA Kit, Species Human, Sample Type serum, plasma Cusabio 96T 981
ASK
Publication
CSB-E12757Pl Plant Sucrose Phosphate Synthase (SPS) ELISA Kit, Species Plant, Sample Type serum, plasma Cusabio 96T 1 CSB-E12757Pl Plant Sucrose Phosphate Synthase (SPS) ELISA Kit, Species Plant, Sample Type serum, plasma Cusabio 96T 1
ASK
Publication
CSB-E17034h Human Helicobacter pylori antibody(IgA) ELISA Kit, Species Human, Sample Type serum, plasma Cusabio 96T 913 CSB-E17034h Human Helicobacter pylori antibody(IgA) ELISA Kit, Species Human, Sample Type serum, plasma Cusabio 96T 913
ASK
Publication
CSB-EL018020BO Bovine prolactin-induced protein (PIP) ELISA kit, Species Bovine, Sample Type serum, plasma Cusabio 96T 913.5 CSB-EL018020BO Bovine prolactin-induced protein (PIP) ELISA kit, Species Bovine, Sample Type serum, plasma Cusabio 96T 913.5
ASK
Publication
CSB-EL022603BO Bovine secreted phosphoprotein 1 (SPP1) ELISA kit, Species Bovine, Sample Type serum, plasma Cusabio 96T 798 CSB-EL022603BO Bovine secreted phosphoprotein 1 (SPP1) ELISA kit, Species Bovine, Sample Type serum, plasma Cusabio 96T 798
ASK
Publication
BC07014a Kidney cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing BC07014; ihc Anti-Actin confirmed US Biomax 185 BC07014a Kidney cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing BC07014; ihc Anti-Actin confirmed US Biomax 185
ASK
Publication
BC11012a Ovary cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing BC11012; ihc Anti-Actin confirmed US Biomax 185 BC11012a Ovary cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing BC11012; ihc Anti-Actin confirmed US Biomax 185
ASK
Publication
BC12011a Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 63 cases 63 cores, replacing BC12011; ihc Anti-Actin confirmed US Biomax 162 BC12011a Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 63 cases 63 cores, replacing BC12011; ihc Anti-Actin confirmed US Biomax 162
ASK
Publication
BR803a Breast cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing BR803; ihc Anti-Actin confirmed US Biomax 258 BR803a Breast cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing BR803; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
BR804a Breast cancer tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores, replacing BR804; ihc Anti-Actin confirmed US Biomax 267 BR804a Breast cancer tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores, replacing BR804; ihc Anti-Actin confirmed US Biomax 267
ASK
Publication
CO804a Colon cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replcing CO804; ihc Anti-Actin confirmed US Biomax 267 CO804a Colon cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replcing CO804; ihc Anti-Actin confirmed US Biomax 267
ASK
Publication
LC726a Lung cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing LC726; ihc Anti-Actin confirmed US Biomax 228 LC726a Lung cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing LC726; ihc Anti-Actin confirmed US Biomax 228
ASK
Publication
OV803a Ovary cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing OV803; ihc Anti-Actin confirmed US Biomax 258 OV803a Ovary cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing OV803; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
PR483a Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing PR483; ihc Anti-Actin confirmed US Biomax 210 PR483a Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing PR483; ihc Anti-Actin confirmed US Biomax 210
ASK
Publication
PR633 Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 63 cases 63 cores, replacing PR8010; ihc Anti-Actin confirmed US Biomax 296 PR633 Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 63 cases 63 cores, replacing PR8010; ihc Anti-Actin confirmed US Biomax 296
ASK
Publication
PR803a Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing PR803; ihc Anti-Actin confirmed US Biomax 296 PR803a Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing PR803; ihc Anti-Actin confirmed US Biomax 296
ASK
Publication
ST483a Stomach cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing ST483; ihc Anti-Actin confirmed US Biomax 185 ST483a Stomach cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing ST483; ihc Anti-Actin confirmed US Biomax 185
ASK
Publication
ST483b Stomach cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing ST483; ihc Anti-Actin confirmed US Biomax 210 ST483b Stomach cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing ST483; ihc Anti-Actin confirmed US Biomax 210
ASK
Publication
T141 Pancreatic cancer test tissue array, with normal pancreas control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 T141 Pancreatic cancer test tissue array, with normal pancreas control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88
ASK
Publication
CSB-EL005272CH Chicken craniofacial development protein 1 (CFDP1) ELISA kit, Species Chicken, Sample Type serum, plasma Cusabio 96T 913.5 CSB-EL005272CH Chicken craniofacial development protein 1 (CFDP1) ELISA kit, Species Chicken, Sample Type serum, plasma Cusabio 96T 913.5
ASK
Publication
CSB-EL022397RB Rabbit superoxide dismutase 1, soluble (SOD1) ELISA kit, Species Rabbit, Sample Type serum, plasma Cusabio 96T 781 CSB-EL022397RB Rabbit superoxide dismutase 1, soluble (SOD1) ELISA kit, Species Rabbit, Sample Type serum, plasma Cusabio 96T 781 Publication
CSB-EL022398RB Rabbit superoxide dismutase 2, mitochondrial (SOD2) ELISA kit, Species Rabbit, Sample Type serum, plasma Cusabio 96T 913 CSB-EL022398RB Rabbit superoxide dismutase 2, mitochondrial (SOD2) ELISA kit, Species Rabbit, Sample Type serum, plasma Cusabio 96T 913 Publication
CSB-EL002499BO Bovine UDP-GlcNAc betaGal beta-1,3-N-acetylglucosaminyltransferase 1 (B3GNT1) ELISA kit, Species Bovine, Sample Type serum, plasma Cusabio 96T 913 CSB-EL002499BO Bovine UDP-GlcNAc betaGal beta-1,3-N-acetylglucosaminyltransferase 1 (B3GNT1) ELISA kit, Species Bovine, Sample Type serum, plasma Cusabio 96T 913
ASK
Publication
CSB-EL010048HU Human guanylate cyclase activator 2B (uroguanylin) (GUCA2B) ELISA kit, Species Human, Sample Type serum, plasma Cusabio 96T 913 CSB-EL010048HU Human guanylate cyclase activator 2B (uroguanylin) (GUCA2B) ELISA kit, Species Human, Sample Type serum, plasma Cusabio 96T 913 Publication
CSB-EL015981MO Mouse neuropeptide FF-amide peptide precursor (NPFF) ELISA kit, Species Mouse, Sample Type serum, plasma Cusabio 96T 913 CSB-EL015981MO Mouse neuropeptide FF-amide peptide precursor (NPFF) ELISA kit, Species Mouse, Sample Type serum, plasma Cusabio 96T 913
ASK
Publication
CSB-EL020623CH Chicken S100 calcium binding protein A10 (S100A10) ELISA kit, Species Chicken, Sample Type serum, plasma Cusabio 96T 913.5 CSB-EL020623CH Chicken S100 calcium binding protein A10 (S100A10) ELISA kit, Species Chicken, Sample Type serum, plasma Cusabio 96T 913.5
ASK
Publication
CSB-EL027233PL Plant solanesyl diphosphate synthase 1(SPS1 SPPS SPS)ELISA kit, Species Plant, Sample Type serum, plasma Cusabio 96T 913 CSB-EL027233PL Plant solanesyl diphosphate synthase 1(SPS1 SPPS SPS)ELISA kit, Species Plant, Sample Type serum, plasma Cusabio 96T 913
ASK
Publication
BC01071a Multiple organ cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing BC01071; ihc Anti-Actin confirmed US Biomax 185 BC01071a Multiple organ cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing BC01071; ihc Anti-Actin confirmed US Biomax 185
ASK
Publication
HN242a Head and neck cancer tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing HN242; ihc Anti-Actin confirmed US Biomax 90 HN242a Head and neck cancer tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing HN242; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
T086b Breast cancer test tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T086a; ihc Anti-Actin confirmed US Biomax 90 T086b Breast cancer test tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T086a; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
T124 Bladder cancer test tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T122; ihc Anti-Actin confirmed US Biomax 90 T124 Bladder cancer test tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T122; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
T195a Prostate cancer test tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T195; ihc Anti-Actin confirmed US Biomax 105 T195a Prostate cancer test tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T195; ihc Anti-Actin confirmed US Biomax 105
ASK
Publication
DS-PB-02075 Rabbit Anti-Mouse VEGF VEGF-A [+Biotin] Antibodies Ray Biotech 50 510 DS-PB-02075 Rabbit Anti-Mouse VEGF VEGF-A [+Biotin] Antibodies Ray Biotech 50 510
ASK
Publication
DS-PB-02109 Goat Anti-Human VEGF VEGF-A [+Biotin] Antibodies Ray Biotech 50 510 DS-PB-02109 Goat Anti-Human VEGF VEGF-A [+Biotin] Antibodies Ray Biotech 50 510
ASK
Publication
CSB-EL027234PL Plant solanesyl diphosphate synthase 2, chloroplastic(SPS2 SPPS)ELISA kit, Species Plant, Sample Type serum, plasma Cusabio 96T 913 CSB-EL027234PL Plant solanesyl diphosphate synthase 2, chloroplastic(SPS2 SPPS)ELISA kit, Species Plant, Sample Type serum, plasma Cusabio 96T 913
ASK
Publication
BL1921 Mid advanced stage bladder cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores US Biomax 456 BL1921 Mid advanced stage bladder cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores US Biomax 456
ASK
Publication
BR1922 Late stage breast cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores US Biomax 456 BR1922 Late stage breast cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores US Biomax 456
ASK
Publication
KD1921 Mid advanced stage kidney cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores US Biomax 456 KD1921 Mid advanced stage kidney cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores US Biomax 456
ASK
Publication
PA1921 Mid advanced stage pancreatic cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores US Biomax 456 PA1921 Mid advanced stage pancreatic cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores US Biomax 456
ASK
Publication
T072 Kidney cancer test tissue array, with normal tissue, TNM, clinical stage and pathology grade, 12 cases 24 cores US Biomax 88 T072 Kidney cancer test tissue array, with normal tissue, TNM, clinical stage and pathology grade, 12 cases 24 cores US Biomax 88
ASK
Publication
T262 Bone cancer test tissue array, with normal control tissue, including TNM and clinical stage, 12 cases 24 cores US Biomax 88 T262 Bone cancer test tissue array, with normal control tissue, including TNM and clinical stage, 12 cases 24 cores US Biomax 88
ASK
Publication
BC07015 Multiple type kidney cancer tissue array with normal tissues, 71 cases 72 cores, replacing BC07012 US Biomax 231 BC07015 Multiple type kidney cancer tissue array with normal tissues, 71 cases 72 cores, replacing BC07012 US Biomax 231
ASK
Publication
BC05115 Colon cancer, metastasize to lymph node and liver, and normal tissue array, including TNM, clinical stage and pathology grade, 68 cases 69 cores, replaced by CO702 US Biomax 231 BC05115 Colon cancer, metastasize to lymph node and liver, and normal tissue array, including TNM, clinical stage and pathology grade, 68 cases 69 cores, replaced by CO702 US Biomax 231
ASK
Publication
OV241a Ovary cancer and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing OV241; ihc Anti-Actin confirmed US Biomax 105 OV241a Ovary cancer and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing OV241; ihc Anti-Actin confirmed US Biomax 105
ASK
Publication
DS-PB-02074 Rabbit Anti-Mouse VEGF VEGF-A Antibodies Ray Biotech 0.1 mg 510 DS-PB-02074 Rabbit Anti-Mouse VEGF VEGF-A Antibodies Ray Biotech 0.1 mg 510
ASK
Publication
DS-PB-02328 Goat Anti-Human VEGF VEGF-A Antibodies Ray Biotech 0.1 mg 510 DS-PB-02328 Goat Anti-Human VEGF VEGF-A Antibodies Ray Biotech 0.1 mg 510
ASK
Publication
ES1921 Middle advanced stage esophagus cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores US Biomax 456 ES1921 Middle advanced stage esophagus cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores US Biomax 456
ASK
Publication
ST1921 Middle advanced stage stomach cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores US Biomax 456 ST1921 Middle advanced stage stomach cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores US Biomax 456
ASK
Publication
T002 Endocrine organ cancer test tissue array, with normal tissue as control, including TNM and clinical stage, 6 cases 24 cores US Biomax 88 T002 Endocrine organ cancer test tissue array, with normal tissue as control, including TNM and clinical stage, 6 cases 24 cores US Biomax 88
ASK
Publication
T022 Esophageal cancer test tissue array, with normal tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores US Biomax 88 T022 Esophageal cancer test tissue array, with normal tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores US Biomax 88
ASK
Publication
T092 Endometrium cancer test tissue array, with normal tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores US Biomax 88 T092 Endometrium cancer test tissue array, with normal tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores US Biomax 88
ASK
Publication
T142 Pancreatic cancer test tissue array, with normal tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores US Biomax 88 T142 Pancreatic cancer test tissue array, with normal tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores US Biomax 88
ASK
Publication
TH208 Thyroid cancer tissue microarray with normal tissue control, high density (60 cases 208 cores), with clinical stage data US Biomax 456 TH208 Thyroid cancer tissue microarray with normal tissue control, high density (60 cases 208 cores), with clinical stage data US Biomax 456
ASK
Publication
CR1921 Middle advanced stage uterine cervix cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores US Biomax 456 CR1921 Middle advanced stage uterine cervix cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores US Biomax 456
ASK
Publication
LC951 Lung cancer tissue array with normal adjacent tissue and metastatic carcinoma, with TNM, clinical stage and survival data, 40 cases 95 cores US Biomax 456 LC951 Lung cancer tissue array with normal adjacent tissue and metastatic carcinoma, with TNM, clinical stage and survival data, 40 cases 95 cores US Biomax 456
ASK
Publication
T012 Stomach cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores US Biomax 88 T012 Stomach cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores US Biomax 88
ASK
Publication
T032 Liver cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores US Biomax 88 T032 Liver cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores US Biomax 88
ASK
Publication
T052 Colon cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores US Biomax 88 T052 Colon cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores US Biomax 88
ASK
Publication
T102 Cervix cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores US Biomax 88 T102 Cervix cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores US Biomax 88
ASK
Publication
T112 Ovary cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores US Biomax 88 T112 Ovary cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores US Biomax 88
ASK
Publication
T122 Bladder cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores US Biomax 88 T122 Bladder cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores US Biomax 88
ASK
Publication
T172 Brain cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores US Biomax 88 T172 Brain cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores US Biomax 88
ASK
Publication
T212 Skin cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores US Biomax 88 T212 Skin cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores US Biomax 88
ASK
Publication
T233 Testis cancer test tissue array, with normal tissue as control, including TNM and clinical stage, 2 serial sections, 6 cases 24 cores US Biomax 88 T233 Testis cancer test tissue array, with normal tissue as control, including TNM and clinical stage, 2 serial sections, 6 cases 24 cores US Biomax 88
ASK
Publication
BR1505 Breast cancer tissue array, including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2, AR and Ki67) results, 75 cases 150 cores, no overlaps with BR1503 or BR1504; ihc Anti-Actin US Biomax 296 BR1505 Breast cancer tissue array, including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2, AR and Ki67) results, 75 cases 150 cores, no overlaps with BR1503 or BR1504; ihc Anti-Actin US Biomax 296
ASK
Publication
CO484a Colon cancer tissue array with adjacent normal tissues, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing CO484; ihc Anti-Actin confirmed US Biomax 210 CO484a Colon cancer tissue array with adjacent normal tissues, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing CO484; ihc Anti-Actin confirmed US Biomax 210
ASK
Publication
CSB-EL010802RB Rabbit heat shock protein 90kDa alpha (cytosolic), class A member 1 (HSP90AA1) ELISA kit, Species Rabbit, Sample Type serum, plasma Cusabio 96T 913 CSB-EL010802RB Rabbit heat shock protein 90kDa alpha (cytosolic), class A member 1 (HSP90AA1) ELISA kit, Species Rabbit, Sample Type serum, plasma Cusabio 96T 913
ASK
Publication
CSB-EL010808RB Rabbit heat shock protein 90kDa alpha (cytosolic), class B member 1 (HSP90AB1) ELISA kit, Species Rabbit, Sample Type serum, plasma Cusabio 96T 913 CSB-EL010808RB Rabbit heat shock protein 90kDa alpha (cytosolic), class B member 1 (HSP90AB1) ELISA kit, Species Rabbit, Sample Type serum, plasma Cusabio 96T 913
ASK
Publication
CO951 Colon cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and survival data, 30 cases 95 cores US Biomax 456 CO951 Colon cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and survival data, 30 cases 95 cores US Biomax 456
ASK
Publication
OV951 Ovary cancer tissue array with matched normal adjacent tissue and metastatic carcinoma, with TNM, clinical stage and survival data, 38 cases 95 cores, US Biomax 456 OV951 Ovary cancer tissue array with matched normal adjacent tissue and metastatic carcinoma, with TNM, clinical stage and survival data, 38 cases 95 cores, US Biomax 456
ASK
Publication
T014 Stomach cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 T014 Stomach cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
T024 Esophageal cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 T024 Esophageal cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
T034 Liver cancer test tissue array (4x (2x3) array) including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 T034 Liver cancer test tissue array (4x (2x3) array) including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
T041 Lung cancer test tissue array, with normal lung control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 T041 Lung cancer test tissue array, with normal lung control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88
ASK
Publication
T046 Lung cancer test tissue array (4x (2x3)array) including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 T046 Lung cancer test tissue array (4x (2x3)array) including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
T051 Colon cancer test tissue array, with normal colon tissues as control, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 T051 Colon cancer test tissue array, with normal colon tissues as control, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88
ASK
Publication
T061 Rectal cancer test tissue array, with normal rectal control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 T061 Rectal cancer test tissue array, with normal rectal control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88
ASK
Publication
T074 Kidney cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 T074 Kidney cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
T089 Breast cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 T089 Breast cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
T095 Endometrium cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 T095 Endometrium cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
T101 Cervix cancer test tissue array, with normal cervix control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 T101 Cervix cancer test tissue array, with normal cervix control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88
ASK
Publication
T111 Ovary cancer test tissue array, with normal ovary control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 T111 Ovary cancer test tissue array, with normal ovary control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88
ASK
Publication
T151 Thyroid cancer test tissue array, with normal thyroid control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 T151 Thyroid cancer test tissue array, with normal thyroid control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88
ASK
Publication
T191 Prostate cancer test tissue array, with normal prostate control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 T191 Prostate cancer test tissue array, with normal prostate control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88
ASK
Publication
T211 Skin cancer test tissue array, with normal skin control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 T211 Skin cancer test tissue array, with normal skin control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88
ASK
Publication
T221 Penis cancer test tissue array, with normal penis control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 T221 Penis cancer test tissue array, with normal penis control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88
ASK
Publication
T231 Testis cancer test tissue array, with normal testis control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 T231 Testis cancer test tissue array, with normal testis control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88
ASK
Publication
OV1005a Ovary disease spectrum (ovarian cancer progression) tissue array, including TNM, clinical stage and pathology grade, 100 cases 100 cores, replacing OV1005; ihc Anti-Actin confirmed US Biomax 267 OV1005a Ovary disease spectrum (ovarian cancer progression) tissue array, including TNM, clinical stage and pathology grade, 100 cases 100 cores, replacing OV1005; ihc Anti-Actin confirmed US Biomax 267
ASK
Publication
BR952 Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores US Biomax 456 BR952 Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores US Biomax 456
ASK
Publication
MGS801 Male genitourinary system tissue array with normal, inflammation, disease and cancer tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores US Biomax 266 MGS801 Male genitourinary system tissue array with normal, inflammation, disease and cancer tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores US Biomax 266
ASK
Publication
OV1005 Ovarian disease spectrum (ovarian cancer progression) tissue array, including TNM, clinical stage and pathology grade, 100 cases 100 cores, replacing OV1001 US Biomax 266 OV1005 Ovarian disease spectrum (ovarian cancer progression) tissue array, including TNM, clinical stage and pathology grade, 100 cases 100 cores, replacing OV1001 US Biomax 266
ASK
Publication
T042 Lung cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by T044 US Biomax 88 T042 Lung cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by T044 US Biomax 88
ASK
Publication
T044 Lung cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by T045 US Biomax 88 T044 Lung cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by T045 US Biomax 88
ASK
Publication
T045 Lung cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by T045b US Biomax 88 T045 Lung cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by T045b US Biomax 88
ASK
Publication
T045b Lung cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T045 US Biomax 99 T045b Lung cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T045 US Biomax 99
ASK
Publication
T083 Breast cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 T083 Breast cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88
ASK
Publication
T085 Breast cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replaced by T088 US Biomax 88 T085 Breast cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replaced by T088 US Biomax 88
ASK
Publication
T173 Brain cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 T173 Brain cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88
ASK
Publication
T223 Penis cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 T223 Penis cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88
ASK
Publication
T242 Soft tissue cancer test tissue array, with normal tissue, including TNM and clinical stage, 12 cases 24 cores US Biomax 88 T242 Soft tissue cancer test tissue array, with normal tissue, including TNM and clinical stage, 12 cases 24 cores US Biomax 88
ASK
Publication
BR1005a Breast cancer and matched metastatic carcinoma of lymph node tissue array, including TNM, clinical stage and pathology grade, 50 cases 100 cores, replacing BR1005; ihc Anti-Actin confirmed US Biomax 296 BR1005a Breast cancer and matched metastatic carcinoma of lymph node tissue array, including TNM, clinical stage and pathology grade, 50 cases 100 cores, replacing BR1005; ihc Anti-Actin confirmed US Biomax 296
ASK
Publication
KD951 Kidney cancer tissue array with matched normal adjacent tissue and metastatic carcinoma, with TNM, clinical stage, pathology grade and survival data, 32 cases 95 cores US Biomax 456 KD951 Kidney cancer tissue array with matched normal adjacent tissue and metastatic carcinoma, with TNM, clinical stage, pathology grade and survival data, 32 cases 95 cores US Biomax 456
ASK
Publication
T047 Non-small cell lung cancer test tissue array (4x (2x3)array) including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 T047 Non-small cell lung cancer test tissue array (4x (2x3)array) including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
T081 Breast cancer test tissue array, with normal breast tissues as control, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replaced by T085 US Biomax 88 T081 Breast cancer test tissue array, with normal breast tissues as control, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replaced by T085 US Biomax 88
ASK
Publication
T113 Ovarian cancer test tissue array, with normal ovary tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 T113 Ovarian cancer test tissue array, with normal ovary tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88
ASK
Publication
T273 Oral cavity cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 T273 Oral cavity cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88
ASK
Publication
T342 Head & Neck cancer test tissue array, with normal tongue and epiglottis control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores US Biomax 88 T342 Head & Neck cancer test tissue array, with normal tongue and epiglottis control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores US Biomax 88
ASK
Publication
BR951 Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores, to be replaced by BR95 US Biomax 456 BR951 Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores, to be replaced by BR95 US Biomax 456
ASK
Publication
BR953 Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores, replacing BR952 US Biomax 456 BR953 Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores, replacing BR952 US Biomax 456
ASK
Publication
BR954 Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores, replacing BR953; ihc US Biomax 429 BR954 Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores, replacing BR953; ihc US Biomax 429
ASK
Publication
LC817 Lung cancer tissue array with matched lymph node metastatic tissue, including TNM, clinical stage and pathology grade, 40 cases 80 cores; ihc Anti-Actin confirmed US Biomax 258 LC817 Lung cancer tissue array with matched lymph node metastatic tissue, including TNM, clinical stage and pathology grade, 40 cases 80 cores; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
OV701 Ovary cancer tissue array, with adjacent normal tissue, including TNM, clinical stage and pathology grade, 70 cases 70 cores, replacing BC111110; ihc Anti-Actin confirmed US Biomax 228 OV701 Ovary cancer tissue array, with adjacent normal tissue, including TNM, clinical stage and pathology grade, 70 cases 70 cores, replacing BC111110; ihc Anti-Actin confirmed US Biomax 228
ASK
Publication
PA242a Pancreas cancer tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing PA242; ihc Anti-Actin confirmed US Biomax 105 PA242a Pancreas cancer tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing PA242; ihc Anti-Actin confirmed US Biomax 105
ASK
Publication
T163 Nose, pharyngeal and laryngeal cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 T163 Nose, pharyngeal and laryngeal cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88
ASK
Publication
CSB-E09530h Human anti-parainfluenza virus IgM antibody, anti-PIV IgM ELISA Kit, Species Human, Sample Type serum, plasma Cusabio 96T 816 CSB-E09530h Human anti-parainfluenza virus IgM antibody, anti-PIV IgM ELISA Kit, Species Human, Sample Type serum, plasma Cusabio 96T 816
ASK
Publication
CSB-EL011843BO Bovine ISG15 ubiquitin-like modifier (ISG15) ELISA kit, Species Bovine, Sample Type serum, plasma Cusabio 96T 913 CSB-EL011843BO Bovine ISG15 ubiquitin-like modifier (ISG15) ELISA kit, Species Bovine, Sample Type serum, plasma Cusabio 96T 913 Publication
HN803a Multiple head and neck cancer tissue array with normal tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing HN803; ihc Anti-Actin confirmed US Biomax 296 HN803a Multiple head and neck cancer tissue array with normal tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing HN803; ihc Anti-Actin confirmed US Biomax 296
ASK
Publication
PA805a Pancreas cancer tissue array with adjacent normal tissue as control, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing PA805; ihc Anti-Actin confirmed US Biomax 296 PA805a Pancreas cancer tissue array with adjacent normal tissue as control, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing PA805; ihc Anti-Actin confirmed US Biomax 296
ASK
Publication
T112a Ovary cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T112; ihc Anti-Actin confirmed US Biomax 90 T112a Ovary cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T112; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
LC501 Tissue array of multi type lung cancer and normal tissue with TNM and grade, 50 cases 50 cores US Biomax 160 LC501 Tissue array of multi type lung cancer and normal tissue with TNM and grade, 50 cases 50 cores US Biomax 160
ASK
Publication
CSB-EL006562HU Human dopachrome tautomerase (dopachrome delta-isomerase, tyrosine-related protein 2) (DCT) ELISA kit, Species Human, Sample Type serum, plasma Cusabio 96T 913 CSB-EL006562HU Human dopachrome tautomerase (dopachrome delta-isomerase, tyrosine-related protein 2) (DCT) ELISA kit, Species Human, Sample Type serum, plasma Cusabio 96T 913 Publication
BC19021 Prostate cancer, adjacent normal tissue and normal tissue array, including TNM, clinical stage and pathology grade, 20 cases 72 cores US Biomax 266 BC19021 Prostate cancer, adjacent normal tissue and normal tissue array, including TNM, clinical stage and pathology grade, 20 cases 72 cores US Biomax 266
ASK
Publication
CO952 Colon cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and survival data, 30 cases 95 cores, replacing CO951; ihc Anti-Cytokeratin (CK) confi US Biomax 429 CO952 Colon cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and survival data, 30 cases 95 cores, replacing CO951; ihc Anti-Cytokeratin (CK) confi US Biomax 429
ASK
Publication
BR8016 Middle advanced stage breast cancer tissue array, with metastasis tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores US Biomax 266 BR8016 Middle advanced stage breast cancer tissue array, with metastasis tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores US Biomax 266
ASK
Publication
BR8017 Middle advanced stage breast cancer tissue array, with metastasis tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores US Biomax 266 BR8017 Middle advanced stage breast cancer tissue array, with metastasis tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores US Biomax 266
ASK
Publication
ES8012 Middle advanced stage esophageal cancer tissue array, with metastasis tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores US Biomax 278 ES8012 Middle advanced stage esophageal cancer tissue array, with metastasis tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores US Biomax 278
ASK
Publication
T121 Bladder cancer test tissue array, with normal bladder tissue as control, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 T121 Bladder cancer test tissue array, with normal bladder tissue as control, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88
ASK
Publication
TH242 Thyroid cancer tissue array with matched adjacent thyroid tissue, including TNM and clinical stage, 12 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 TH242 Thyroid cancer tissue array with matched adjacent thyroid tissue, including TNM and clinical stage, 12 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
T421 Small intestine cancer test tissue array, with normal small intestine tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 T421 Small intestine cancer test tissue array, with normal small intestine tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88
ASK
Publication
OR601a Oral squamous cell cancer tissue array with adjacent normal tongue tissue, including TNM, clinical stage and pathology grade, 60 cases 60 cores, replacing OR601; ihc Anti-Actin confirmed US Biomax 258 OR601a Oral squamous cell cancer tissue array with adjacent normal tongue tissue, including TNM, clinical stage and pathology grade, 60 cases 60 cores, replacing OR601; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
T087a Breast cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores, replacing T087; ihc Anti-Actin confirmed US Biomax 90 T087a Breast cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores, replacing T087; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
BL244 Bladder cancer tissue array with matched adjacent bladder tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores; ihc Anti-Actin confirmed US Biomax 105 BL244 Bladder cancer tissue array with matched adjacent bladder tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores; ihc Anti-Actin confirmed US Biomax 105
ASK
Publication
BR1503a Breast cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores, with IHC results of Her-2, ER, PR, AR, P53 and Ki67, 75 cases 150 cores, replacing BR1503; ihc Anti- US Biomax 296 BR1503a Breast cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores, with IHC results of Her-2, ER, PR, AR, P53 and Ki67, 75 cases 150 cores, replacing BR1503; ihc Anti- US Biomax 296
ASK
Publication
CO802a Colon cancer tissue array with adjacent normal colon tissue, including TNM and clinical stage, 80 cases 80 cores, replacing CO802; ihc Anti-Actin confirmed US Biomax 258 CO802a Colon cancer tissue array with adjacent normal colon tissue, including TNM and clinical stage, 80 cases 80 cores, replacing CO802; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
CR245 Cervical cancer tissue array with matched adjacent cervical tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores; ihc Anti-Actin confirmed US Biomax 105 CR245 Cervical cancer tissue array with matched adjacent cervical tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores; ihc Anti-Actin confirmed US Biomax 105
ASK
Publication
LC488 Lung cancer tissue array with matched adjacent lung tissue, including TNM, clinical stage and pathology grade, 16 cases 48 cores; ihc Anti-Actin confirmed US Biomax 185 LC488 Lung cancer tissue array with matched adjacent lung tissue, including TNM, clinical stage and pathology grade, 16 cases 48 cores; ihc Anti-Actin confirmed US Biomax 185
ASK
Publication
LV2091 Liver cancer tissue array with normal liver tissue as control, including TNM, clinical stage and pathology grade, 208 cases 208 cores; ihc Anti-Actin confirmed US Biomax 429 LV2091 Liver cancer tissue array with normal liver tissue as control, including TNM, clinical stage and pathology grade, 208 cases 208 cores; ihc Anti-Actin confirmed US Biomax 429
ASK
Publication
ST2091 Stomach cancer tissue array with adjacent normal stomach tissue, including TNM and clinical stage, 208 cases 208 cores, replacing ST2001; ihc Anti-Actin confirmed US Biomax 487 ST2091 Stomach cancer tissue array with adjacent normal stomach tissue, including TNM and clinical stage, 208 cases 208 cores, replacing ST2001; ihc Anti-Actin confirmed US Biomax 487
ASK
Publication
T013 Stomach cancer test tissue array, with normal stomach tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 T013 Stomach cancer test tissue array, with normal stomach tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88
ASK
Publication
T033 Liver cancer test tissue array, with normal liver tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 T033 Liver cancer test tissue array, with normal liver tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88
ASK
Publication
T043 Lung cancer test tissue array, with normal lung tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 T043 Lung cancer test tissue array, with normal lung tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88
ASK
Publication
T053 Colon cancer test tissue array, with normal colon tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 T053 Colon cancer test tissue array, with normal colon tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88
ASK
Publication
T063 Rectum cancer test tissue array, with normal rectum tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 T063 Rectum cancer test tissue array, with normal rectum tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88
ASK
Publication
T073 Kidney cancer test tissue array, with normal kidney tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 T073 Kidney cancer test tissue array, with normal kidney tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88
ASK
Publication
T123 Bladder cancer test tissue array, with normal bladder tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 T123 Bladder cancer test tissue array, with normal bladder tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88
ASK
Publication
T143 Pancreatic cancer test tissue array, with normal pancreatic tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 T143 Pancreatic cancer test tissue array, with normal pancreatic tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88
ASK
Publication
T193 Prostate cancer test tissue array, with normal prostate tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 T193 Prostate cancer test tissue array, with normal prostate tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88
ASK
Publication
UT243 Endometrium cancer tissue array with matched adjacent endometrium tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 UT243 Endometrium cancer tissue array with matched adjacent endometrium tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
BC041115a Lung cancer tissue array with normal lung tissue, including TNM, clinical stage and pathology grade, 120 cases 120 cores, replacing BC041115; ihc Anti-Actin confirmed US Biomax 296 BC041115a Lung cancer tissue array with normal lung tissue, including TNM, clinical stage and pathology grade, 120 cases 120 cores, replacing BC041115; ihc Anti-Actin confirmed US Biomax 296
ASK
Publication
PA961a Pancreatic cancer tissue array with normal pancreatic tissue, including TNM, clinical stage and pathology grade, 96 cases 96 cores, replacing PA961; ihc Anti-Actin confirmed US Biomax 258 PA961a Pancreatic cancer tissue array with normal pancreatic tissue, including TNM, clinical stage and pathology grade, 96 cases 96 cores, replacing PA961; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
ST801a Stomach cancer tissue array with matched adjacent normal stomach tissue, including TNM and clinical stage, 40 cases 80 cores, replacing ST801; ihc Anti-Actin confirmed US Biomax 267 ST801a Stomach cancer tissue array with matched adjacent normal stomach tissue, including TNM and clinical stage, 40 cases 80 cores, replacing ST801; ihc Anti-Actin confirmed US Biomax 267
ASK
Publication
T153 Thyroid cancer test tissue array, with normal thyroid gland tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 T153 Thyroid cancer test tissue array, with normal thyroid gland tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88
ASK
Publication
CO2085b TMA BLOCK of high density (208 cases 208 cores), multiple type colon adenocarcinoma (I 4 grade) with normal colon from autopsy and cancer adjacent tissue US Biomax 40981 CO2085b TMA BLOCK of high density (208 cases 208 cores), multiple type colon adenocarcinoma (I 4 grade) with normal colon from autopsy and cancer adjacent tissue US Biomax 40981
ASK
Publication
BR243e Breast cancer tissue array with adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing BR243a; ihc Anti-Actin confirmed US Biomax 90 BR243e Breast cancer tissue array with adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing BR243a; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
BRN801a Breast adjacent normal tissue array with breast cancer tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing BRN801; ihc Anti-Actin confirmed US Biomax 258 BRN801a Breast adjacent normal tissue array with breast cancer tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing BRN801; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
CO241a Colon cancer tissue array with adjacent normal colon tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing CO241; ihc Anti-Actin confirmed US Biomax 105 CO241a Colon cancer tissue array with adjacent normal colon tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing CO241; ihc Anti-Actin confirmed US Biomax 105
ASK
Publication
PR242a Prostate cancer tissue array with adjacent normal prostate tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing PR242; ihc Anti-Actin confirmed US Biomax 105 PR242a Prostate cancer tissue array with adjacent normal prostate tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing PR242; ihc Anti-Actin confirmed US Biomax 105
ASK
Publication
PR243a Prostate cancer tissue array with adjacent normal prostate tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing PR243; ihc Anti-Actin confirmed US Biomax 105 PR243a Prostate cancer tissue array with adjacent normal prostate tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing PR243; ihc Anti-Actin confirmed US Biomax 105
ASK
Publication
T054a Colon cancer tissue array with normal colon tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T054; ihc Anti-Actin confirmed US Biomax 90 T054a Colon cancer tissue array with normal colon tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T054; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
BC09012 Endometrial carcinoma (multi tissue combined panel) tissue array, 63 cases 63 cores US Biomax 231 BC09012 Endometrial carcinoma (multi tissue combined panel) tissue array, 63 cases 63 cores US Biomax 231
ASK
Publication
BC05118a Colon cancer tissue array with matched adjacent normal colon tissue, including TNM, clinical stage and pathology grade, 50 cases 100 cores, replacing BC05118; ihc Anti-Actin confirmed US Biomax 296 BC05118a Colon cancer tissue array with matched adjacent normal colon tissue, including TNM, clinical stage and pathology grade, 50 cases 100 cores, replacing BC05118; ihc Anti-Actin confirmed US Biomax 296
ASK
Publication
BR243c Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replaced by BR243d; ihc Anti-Actin confirmed US Biomax 90 BR243c Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replaced by BR243d; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
BR243d Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing BR243c; ihc Anti-Actin confirmed US Biomax 90 BR243d Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing BR243c; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
BR243f Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing BR243a; ihc Anti-Actin confirmed US Biomax 90 BR243f Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing BR243a; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
00178-V HIV type O envelope antigen. Synthetic HIV type O peptide, containing the HIV type O envelope derived sequence. Virogen 100 µg 280 00178-V HIV type O envelope antigen. Synthetic HIV type O peptide, containing the HIV type O envelope derived sequence. Virogen 100 µg 280
ASK
Publication
T113a Ovary cancer test tissue array with normal ovary tissue, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores, replacing T113; ihc Anti-Actin confirmed US Biomax 90 T113a Ovary cancer test tissue array with normal ovary tissue, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores, replacing T113; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
T241 Soft tissue cancer test tissue array, with normal soft tissue control tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 T241 Soft tissue cancer test tissue array, with normal soft tissue control tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88
ASK
Publication
T261 Bone and cartilage cancer test tissue array, with normal bone and cartilage tissue as control, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 T261 Bone and cartilage cancer test tissue array, with normal bone and cartilage tissue as control, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88
ASK
Publication
T192 Prostate cancer test tissue array, with normal control tissue, including TNM, clinical stage, pathology grade, gleason grade and gleason score, 12 cases 24 cores, replaced by T195 US Biomax 88 T192 Prostate cancer test tissue array, with normal control tissue, including TNM, clinical stage, pathology grade, gleason grade and gleason score, 12 cases 24 cores, replaced by T195 US Biomax 88
ASK
Publication
HN241a Head and neck cancer tissue array with adjacent normal head and neck tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing HN241; ihc Anti-Actin confirmed US Biomax 90 HN241a Head and neck cancer tissue array with adjacent normal head and neck tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing HN241; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
CO2085a High density (208 cases 208 cores), multiple type colon adenocarcinoma (I 4 grade) tissue array with normal colon from autopsy and cancer adjacent tissue US Biomax 456 CO2085a High density (208 cases 208 cores), multiple type colon adenocarcinoma (I 4 grade) tissue array with normal colon from autopsy and cancer adjacent tissue US Biomax 456
ASK
Publication
ICY-SER Animal Biologicals Pooled Serum Cynomolgus Monkey Serum Innovative Research INC 10ml 144 ICY-SER Animal Biologicals Pooled Serum Cynomolgus Monkey Serum Innovative Research INC 10ml 144 Publication
IRS-SER Animal Biologicals Pooled Serum Rhesus Monkey Serum Innovative Research INC 10ml 133 IRS-SER Animal Biologicals Pooled Serum Rhesus Monkey Serum Innovative Research INC 10ml 133 Publication
IMS-CD1-SER Animal Biologicals Pooled Serum CD-1 Mouse Serum Innovative Research INC 50ml 219 IMS-CD1-SER Animal Biologicals Pooled Serum CD-1 Mouse Serum Innovative Research INC 50ml 219 Publication
IRAAP0048-2ml Goat antiChicken Whole Serum Whole Serum 2ml Innovative Research INC 2ml 227 IRAAP0048-2ml Goat antiChicken Whole Serum Whole Serum 2ml Innovative Research INC 2ml 227 Publication
IRAAP0113-2ml Goat antiHorse Whole Serum Whole Serum 2ml Innovative Research INC 2ml 199 IRAAP0113-2ml Goat antiHorse Whole Serum Whole Serum 2ml Innovative Research INC 2ml 199
ASK
Publication
IRAAP0114-2ml Rabbit antiHorse Whole Serum Whole Serum 2ml Innovative Research INC 2ml 199 IRAAP0114-2ml Rabbit antiHorse Whole Serum Whole Serum 2ml Innovative Research INC 2ml 199
ASK
Publication
KD991 Kidney cancer tissue array with matched cancer adjacent and cancer adjacent normal tissue, 33 cases 99 cores US Biomax 231 KD991 Kidney cancer tissue array with matched cancer adjacent and cancer adjacent normal tissue, 33 cases 99 cores US Biomax 231
ASK
Publication
IRAAP0113 Antibodies, Horse: Goat anti-Horse Whole Serum Whole Serum Innovative Research INC 2ml 144 IRAAP0113 Antibodies, Horse: Goat anti-Horse Whole Serum Whole Serum Innovative Research INC 2ml 144
ASK
Publication
IRAAP0114 Antibodies, Horse: Rabbit anti-Horse Whole Serum Whole Serum Innovative Research INC 2ml 144 IRAAP0114 Antibodies, Horse: Rabbit anti-Horse Whole Serum Whole Serum Innovative Research INC 2ml 144
ASK
Publication
CLC601 Colon cancer and lung cancer tissue array, including TNM and pathology grade, 60 cases 60 cores US Biomax 266 CLC601 Colon cancer and lung cancer tissue array, including TNM and pathology grade, 60 cases 60 cores US Biomax 266
ASK
Publication
LV803 Liver carcinoma (combination of cancer, cancer adjacent and normal tissue), 53 cases 72 cores, replacing BC03021 US Biomax 231 LV803 Liver carcinoma (combination of cancer, cancer adjacent and normal tissue), 53 cases 72 cores, replacing BC03021 US Biomax 231
ASK
Publication
MC643 Multiple cancer tissue array II, 6 common types of cancer and some of matched normal tissues, with TNM data, 58 cases 66 cores US Biomax 0 MC643 Multiple cancer tissue array II, 6 common types of cancer and some of matched normal tissues, with TNM data, 58 cases 66 cores US Biomax 0
ASK
Publication
MC644 Multiple cancer tissue array III, 6 common types of cancer and some of matched normal tissues, with TNM data, 58 cases 66 cores US Biomax 0 MC644 Multiple cancer tissue array III, 6 common types of cancer and some of matched normal tissues, with TNM data, 58 cases 66 cores US Biomax 0
ASK
Publication
ISTMC-N Cancer Samples: Gastric Carcinoma Cancer Plasma Innovative Research INC Each 266 ISTMC-N Cancer Samples: Gastric Carcinoma Cancer Plasma Innovative Research INC Each 266
ASK
Publication
IQ288 Mouse AntiCytokeratin (keratin) type I (AE1) Target Antigen Cytokeratin (keratin) type I ( AE1) Host Isotype Mouse IgG1 Application EM; IB; IHC(P) Imunquest 0.2ml 492 IQ288 Mouse AntiCytokeratin (keratin) type I (AE1) Target Antigen Cytokeratin (keratin) type I ( AE1) Host Isotype Mouse IgG1 Application EM; IB; IHC(P) Imunquest 0.2ml 492
ASK
Publication
IQ289 Mouse AntiCytokeratin (keratin) type II, AE3 Target Antigen Cytokeratin (keratin) type II (AE3) Host Isotype Mouse IgG1 Application EM; IB; IHC (P) Imunquest 0.2ml 492 IQ289 Mouse AntiCytokeratin (keratin) type II, AE3 Target Antigen Cytokeratin (keratin) type II (AE3) Host Isotype Mouse IgG1 Application EM; IB; IHC (P) Imunquest 0.2ml 492
ASK
Publication
IOVC-N Cancer Samples: Ovarian Cancer Plasma Innovative Research INC Each 313 IOVC-N Cancer Samples: Ovarian Cancer Plasma Innovative Research INC Each 313
ASK
Publication
LF-MA0106 anti-Human Serum Albumin (1G2), Mouse monoclonal to Human Serum Albumin, Isotype IgG1, Host Mouse Abfrontier 100 ul 355 LF-MA0106 anti-Human Serum Albumin (1G2), Mouse monoclonal to Human Serum Albumin, Isotype IgG1, Host Mouse Abfrontier 100 ul 355 Publication
LF-MA0160 anti-Serum amyloid P component (6E6), Mouse monoclonal to Serum amyloid P component, Isotype IgG1, Host Mouse Abfrontier 100 ul 355 LF-MA0160 anti-Serum amyloid P component (6E6), Mouse monoclonal to Serum amyloid P component, Isotype IgG1, Host Mouse Abfrontier 100 ul 355 Publication
BC08014 Breast cancer (multiple types of breast cancer) tissue array, 63 cases 63 cores, replaced by BR8018 US Biomax 160 BC08014 Breast cancer (multiple types of breast cancer) tissue array, 63 cases 63 cores, replaced by BR8018 US Biomax 160
ASK
Publication
KD241 Kidney cancer test tissue array with matched cancer adjacent normal tissue, 6 cases 24 cores US Biomax 88 KD241 Kidney cancer test tissue array with matched cancer adjacent normal tissue, 6 cases 24 cores US Biomax 88
ASK
Publication
CR2083 Uterine cervical cancer and cancer adjacent normal tissue survey tissue array (1 of 5), including TNM and pathology grade, 104 cases 208 cores US Biomax 456 CR2083 Uterine cervical cancer and cancer adjacent normal tissue survey tissue array (1 of 5), including TNM and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
E0973r ELISA Agtr2,Angiotensin II type-2 receptor,AT2,Rat,Rattus norvegicus,Type-2 angiotensin II receptor EIAab 96T 845 E0973r ELISA Agtr2,Angiotensin II type-2 receptor,AT2,Rat,Rattus norvegicus,Type-2 angiotensin II receptor EIAab 96T 845 Publication
000073A VEGF ABM Goods 250ul 621 000073A VEGF ABM Goods 250ul 621
ASK
Publication
000265A VEGF R1 ABM Goods 250ul 621 000265A VEGF R1 ABM Goods 250ul 621
ASK
Publication
000279A VEGF B ABM Goods 250ul 621 000279A VEGF B ABM Goods 250ul 621
ASK
Publication
000280A VEGF D ABM Goods 250ul 621 000280A VEGF D ABM Goods 250ul 621
ASK
Publication
000617A VEGF ABM Goods 250ul 621 000617A VEGF ABM Goods 250ul 621
ASK
Publication
000641A VEGF R2 ABM Goods 250ul 621 000641A VEGF R2 ABM Goods 250ul 621
ASK
Publication
3489-100 EG-VEGF Antibody Biovision 100 301.455 3489-100 EG-VEGF Antibody Biovision 100 301.455
ASK
Publication
3489-100 EG VEGF Antibody Biovision 100 µl 341.145 3489-100 EG VEGF Antibody Biovision 100 µl 341.145
ASK
Publication
3489-100 EG VEGF Polyclonal Ab 100 ug Biovision 100 ug 257.985 3489-100 EG VEGF Polyclonal Ab 100 ug Biovision 100 ug 257.985
ASK
Publication
3489R-100 EG-VEGF Antibody Biovision 100 280.665 3489R-100 EG-VEGF Antibody Biovision 100 280.665
ASK
Publication
3489R-100 EG VEGF Antibody Biovision 100 µg 341 3489R-100 EG VEGF Antibody Biovision 100 µg 341
ASK
Publication
3489R-100 EG VEGF Polyclonal Ab 100 ug Biovision 100 ug 230.58 3489R-100 EG VEGF Polyclonal Ab 100 ug Biovision 100 ug 230.58
ASK
Publication
4635-10 VEGF-C, rat recombinant Biovision 10 μg 247 4635-10 VEGF-C, rat recombinant Biovision 10 μg 247 Publication
4635-1000 VEGF-C, rat recombinant Biovision 1 mg 3942 4635-1000 VEGF-C, rat recombinant Biovision 1 mg 3942 Publication
4635-50 VEGF-C, rat recombinant Biovision 50 μg 661 4635-50 VEGF-C, rat recombinant Biovision 50 μg 661 Publication
5363-100 VEGF Antibody Biovision 100 281 5363-100 VEGF Antibody Biovision 100 281
ASK
Publication
5365-100 VEGF Antibody Biovision 100 µg 341 5365-100 VEGF Antibody Biovision 100 µg 341 Publication
5633-100 VEGF-C Antibody Biovision 100 353 5633-100 VEGF-C Antibody Biovision 100 353
ASK
Publication
5633-100 VEGF C Antibody Biovision 100 µg 431.411 5633-100 VEGF C Antibody Biovision 100 µg 431.411
ASK
Publication
5633R-100 VEGF C Antibody Biovision 100 µg 341 5633R-100 VEGF C Antibody Biovision 100 µg 341 Publication
5641-100 VEGF B Antibody Biovision 100 µg 282 5641-100 VEGF B Antibody Biovision 100 µg 282 Publication
5643-100 VEGF D Antibody Biovision 100 µg 341 5643-100 VEGF D Antibody Biovision 100 µg 341 Publication
LC2085a High density (188 cases 208 cores), multiple types of lung cancer (I 3 grade) tissue array with normal lung from autopsy and cancer adjacent tissue US Biomax 456 LC2085a High density (188 cases 208 cores), multiple types of lung cancer (I 3 grade) tissue array with normal lung from autopsy and cancer adjacent tissue US Biomax 456
ASK
Publication
AA0016 Cancer Apoptosis Phospho-Specific Array includes 155 highly specific and well-characterized phosphorylation antibodies in the Cancer Apoptosis pathway. Abnova 2 Pieces/Box 822 AA0016 Cancer Apoptosis Phospho-Specific Array includes 155 highly specific and well-characterized phosphorylation antibodies in the Cancer Apoptosis pathway. Abnova 2 Pieces/Box 822
ASK
Publication
104-PA10S Rabbit anti VEGF-C (rat) AngoiPro 100.00 ug 398 104-PA10S Rabbit anti VEGF-C (rat) AngoiPro 100.00 ug 398 Publication
104-PA12 Rabbit anti VEGF-D (rat) AngoiPro 100.00 ug 398 104-PA12 Rabbit anti VEGF-D (rat) AngoiPro 100.00 ug 398 Publication
228-11620-1 Recombinant Rat VEGF-C Proteins Ray Biotech 2 147 228-11620-1 Recombinant Rat VEGF-C Proteins Ray Biotech 2 147 Publication
228-11620-2 Recombinant Rat VEGF-C Proteins Ray Biotech 10 205 228-11620-2 Recombinant Rat VEGF-C Proteins Ray Biotech 10 205 Publication
228-11620-3 Recombinant Rat VEGF-C Proteins Ray Biotech 1mg 0 228-11620-3 Recombinant Rat VEGF-C Proteins Ray Biotech 1mg 0 Publication
228-11622-1 Recombinant Rat VEGF-C (152 aa) Proteins Ray Biotech 2 147 228-11622-1 Recombinant Rat VEGF-C (152 aa) Proteins Ray Biotech 2 147
ASK
Publication
228-11622-2 Recombinant Rat VEGF-C (152 aa) Proteins Ray Biotech 10 205 228-11622-2 Recombinant Rat VEGF-C (152 aa) Proteins Ray Biotech 10 205
ASK
Publication
228-11622-3 Recombinant Rat VEGF-C (152 aa) Proteins Ray Biotech 1mg 0 228-11622-3 Recombinant Rat VEGF-C (152 aa) Proteins Ray Biotech 1mg 0
ASK
Publication
3565-100 VEGF D Polyclonal Ab[DISCONTINUED] Biovision 100 µg 354.526 3565-100 VEGF D Polyclonal Ab[DISCONTINUED] Biovision 100 µg 354.526
ASK
Publication
4571-10 EG-VEGF, human recombinant Biovision 10 μg 149 4571-10 EG-VEGF, human recombinant Biovision 10 μg 149
ASK
Publication
4571-1000 EG VEGF, human recombinant Biovision 1 mg 3072 4571-1000 EG VEGF, human recombinant Biovision 1 mg 3072
ASK
Publication
4571-50 EG-VEGF, human recombinant Biovision 50 μg 385 4571-50 EG-VEGF, human recombinant Biovision 50 μg 385
ASK
Publication
4633-10 VEGF-C, human recombinant Biovision 10 μg 247 4633-10 VEGF-C, human recombinant Biovision 10 μg 247
ASK
Publication
4633-1000 VEGF C, human recombinant Biovision 1 mg 3123 4633-1000 VEGF C, human recombinant Biovision 1 mg 3123
ASK
Publication
4633-50 VEGF-C, human recombinant Biovision 50 μg 661 4633-50 VEGF-C, human recombinant Biovision 50 μg 661
ASK
Publication
4634-10 VEGF C, murine recombinant Biovision 10 ìg 245 4634-10 VEGF C, murine recombinant Biovision 10 ìg 245
ASK
Publication
4634-1000 VEGF C, murine recombinant Biovision 1 mg 3942 4634-1000 VEGF C, murine recombinant Biovision 1 mg 3942
ASK
Publication
4634-50 VEGF-C, murine recombinant Biovision 50 μg 661 4634-50 VEGF-C, murine recombinant Biovision 50 μg 661
ASK
Publication
4642-100 VEGF B, human recombinant Biovision 100 ìg 571 4642-100 VEGF B, human recombinant Biovision 100 ìg 571 Publication
4642-1000 VEGF B, human recombinant Biovision 1 mg 3584 4642-1000 VEGF B, human recombinant Biovision 1 mg 3584 Publication
4642-20 VEGF-B, human recombinant Biovision 20 μg 241 4642-20 VEGF-B, human recombinant Biovision 20 μg 241 Publication
4643-10 VEGF-D, human recombinant Biovision 10 μg 241 4643-10 VEGF-D, human recombinant Biovision 10 μg 241 Publication
4643-1000 VEGF D, human recombinant Biovision 1 mg 5017 4643-1000 VEGF D, human recombinant Biovision 1 mg 5017 Publication
4643-50 VEGF-D, human recombinant Biovision 50 μg 661 4643-50 VEGF-D, human recombinant Biovision 50 μg 661 Publication
5633-100 VEGF C Polyclonal Antibody100 ug Biovision 100 ug 325.77 5633-100 VEGF C Polyclonal Antibody100 ug Biovision 100 ug 325.77
ASK
Publication
rAP-0001-20 EG-VEGF recombinant proteins AngoiPro 20.00 ug 279 rAP-0001-20 EG-VEGF recombinant proteins AngoiPro 20.00 ug 279 Publication
rAP-0001-5 EG-VEGF recombinant proteins AngoiPro 5.00 ug 133 rAP-0001-5 EG-VEGF recombinant proteins AngoiPro 5.00 ug 133 Publication
rAP-0008-10 VEGF (Rat) recombinant proteins AngoiPro 10.00 ug 279 rAP-0008-10 VEGF (Rat) recombinant proteins AngoiPro 10.00 ug 279 Publication
rAP-0008-2 VEGF (Rat) recombinant proteins AngoiPro 2.00 ug 133 rAP-0008-2 VEGF (Rat) recombinant proteins AngoiPro 2.00 ug 133 Publication
rAP-0012-10 VEGF-C (Rat) recombinant proteins AngoiPro 10.00 ug 279 rAP-0012-10 VEGF-C (Rat) recombinant proteins AngoiPro 10.00 ug 279 Publication
rAP-0012-2 VEGF-C (Rat) recombinant proteins AngoiPro 2.00 ug 133 rAP-0012-2 VEGF-C (Rat) recombinant proteins AngoiPro 2.00 ug 133 Publication
102-PA02S Rabbit anti VEGF-A (human) AngoiPro 100.00 ug 398 102-PA02S Rabbit anti VEGF-A (human) AngoiPro 100.00 ug 398 Publication
102-PA03AG Rabbit anti VEGF-A (human) AngoiPro 50.00 ug 398 102-PA03AG Rabbit anti VEGF-A (human) AngoiPro 50.00 ug 398 Publication
102-PA03S Rabbit anti VEGF-A pan (human) AngoiPro 100.00 ug 398 102-PA03S Rabbit anti VEGF-A pan (human) AngoiPro 100.00 ug 398 Publication
103-PA03AG Rabbit anti VEGF-A (mouse) AngoiPro 50.00 ug 398 103-PA03AG Rabbit anti VEGF-A (mouse) AngoiPro 50.00 ug 398 Publication
103-PA03S Rabbit anti VEGF-A (mouse) AngoiPro 100.00 ug 398 103-PA03S Rabbit anti VEGF-A (mouse) AngoiPro 100.00 ug 398 Publication
228-10359-1 Recombinant Human EG-VEGF PK1 Proteins Ray Biotech 5 147 228-10359-1 Recombinant Human EG-VEGF PK1 Proteins Ray Biotech 5 147 Publication
228-10359-2 Recombinant Human EG-VEGF PK1 Proteins Ray Biotech 20 205 228-10359-2 Recombinant Human EG-VEGF PK1 Proteins Ray Biotech 20 205 Publication
228-10359-3 Recombinant Human EG-VEGF PK1 Proteins Ray Biotech 1mg 2426 228-10359-3 Recombinant Human EG-VEGF PK1 Proteins Ray Biotech 1mg 2426 Publication
228-11613-1 Recombinant Rat VEGF VEGFA Proteins Ray Biotech 2 147 228-11613-1 Recombinant Rat VEGF VEGFA Proteins Ray Biotech 2 147 Publication
228-11613-2 Recombinant Rat VEGF VEGFA Proteins Ray Biotech 10 205 228-11613-2 Recombinant Rat VEGF VEGFA Proteins Ray Biotech 10 205 Publication
228-11613-3 Recombinant Rat VEGF VEGFA Proteins Ray Biotech 1mg 0 228-11613-3 Recombinant Rat VEGF VEGFA Proteins Ray Biotech 1mg 0 Publication
228-11621-1 Recombinant Human VEGF-C Proteins Ray Biotech 2 147 228-11621-1 Recombinant Human VEGF-C Proteins Ray Biotech 2 147
ASK
Publication
228-11621-2 Recombinant Human VEGF-C Proteins Ray Biotech 10 205 228-11621-2 Recombinant Human VEGF-C Proteins Ray Biotech 10 205
ASK
Publication
228-11621-3 Recombinant Human VEGF-C Proteins Ray Biotech 1mg 0 228-11621-3 Recombinant Human VEGF-C Proteins Ray Biotech 1mg 0
ASK
Publication
228-11624-1 Recombinant Sheep VEGF-E Proteins Ray Biotech 2 147 228-11624-1 Recombinant Sheep VEGF-E Proteins Ray Biotech 2 147
ASK
Publication
228-11624-2 Recombinant Sheep VEGF-E Proteins Ray Biotech 10 205 228-11624-2 Recombinant Sheep VEGF-E Proteins Ray Biotech 10 205
ASK
Publication
228-11624-3 Recombinant Sheep VEGF-E Proteins Ray Biotech 1mg 0 228-11624-3 Recombinant Sheep VEGF-E Proteins Ray Biotech 1mg 0
ASK
Publication
3565-100 VEGF D Polyclonal Ab100 ug[DISCONTINUED] Biovision 100 ug 269.212 3565-100 VEGF D Polyclonal Ab100 ug[DISCONTINUED] Biovision 100 ug 269.212
ASK
Publication
ELH-EGVEGF-001 Human EG-VEGF Ray Biotech One 96-Well Strip Microplate Kit 542 ELH-EGVEGF-001 Human EG-VEGF Ray Biotech One 96-Well Strip Microplate Kit 542 Publication
IRKFAP0104-5ug Interleukins Recombinant Bovine VEGF-A Innovative Research INC 245 IRKFAP0104-5ug Interleukins Recombinant Bovine VEGF-A Innovative Research INC 245
ASK
Publication
IRKFAP0248-5ug Interleukins Recombinant Equine VEGF-A Innovative Research INC 245 IRKFAP0248-5ug Interleukins Recombinant Equine VEGF-A Innovative Research INC 245
ASK
Publication
IRKFAP0290-5ug Interleukins Recombinant Mouse VEGF-A Innovative Research INC 245 IRKFAP0290-5ug Interleukins Recombinant Mouse VEGF-A Innovative Research INC 245
ASK
Publication
IRKFAP0320-5ug Interleukins Recombinant Swine VEGF-A Innovative Research INC 245 IRKFAP0320-5ug Interleukins Recombinant Swine VEGF-A Innovative Research INC 245
ASK
Publication
rAP-0002-10 VEGF (Human) recombinant proteins AngoiPro 10.00 ug 279 rAP-0002-10 VEGF (Human) recombinant proteins AngoiPro 10.00 ug 279 Publication
rAP-0002-2 VEGF (Human) recombinant proteins AngoiPro 2.00 ug 133 rAP-0002-2 VEGF (Human) recombinant proteins AngoiPro 2.00 ug 133 Publication
rAP-0003-1 VEGF His (Human) recombinant proteins AngoiPro 1.00 ug 133 rAP-0003-1 VEGF His (Human) recombinant proteins AngoiPro 1.00 ug 133 Publication
rAP-0003-10 VEGF His (Human) recombinant proteins AngoiPro 10.00 ug 279 rAP-0003-10 VEGF His (Human) recombinant proteins AngoiPro 10.00 ug 279 Publication
rAP-0004-1 VEGF (Human) CHO recombinant proteins AngoiPro 1.00 ug 133 rAP-0004-1 VEGF (Human) CHO recombinant proteins AngoiPro 1.00 ug 133 Publication
rAP-0004-10 VEGF (Human) CHO recombinant proteins AngoiPro 10.00 ug 279 rAP-0004-10 VEGF (Human) CHO recombinant proteins AngoiPro 10.00 ug 279 Publication
rAP-0005-10 VEGF (Human) Sf9 recombinant proteins AngoiPro 10.00 ug 279 rAP-0005-10 VEGF (Human) Sf9 recombinant proteins AngoiPro 10.00 ug 279 Publication
rAP-0005-2 VEGF (Human) Sf9 recombinant proteins AngoiPro 2.00 ug 133 rAP-0005-2 VEGF (Human) Sf9 recombinant proteins AngoiPro 2.00 ug 133 Publication
rAP-0006-10 VEGF (Mouse) recombinant proteins AngoiPro 10.00 ug 133 rAP-0006-10 VEGF (Mouse) recombinant proteins AngoiPro 10.00 ug 133 Publication
rAP-0006-2 VEGF (Mouse) recombinant proteins AngoiPro 2.00 ug 133 rAP-0006-2 VEGF (Mouse) recombinant proteins AngoiPro 2.00 ug 133 Publication
rAP-0007-10 VEGF (Mouse) Sf9 recombinant proteins AngoiPro 10.00 ug 279 rAP-0007-10 VEGF (Mouse) Sf9 recombinant proteins AngoiPro 10.00 ug 279 Publication
rAP-0007-2 VEGF (Mouse) Sf9 recombinant proteins AngoiPro 2.00 ug 133 rAP-0007-2 VEGF (Mouse) Sf9 recombinant proteins AngoiPro 2.00 ug 133 Publication
rAP-0009-1 VEGF-121 (Human) recombinant proteins AngoiPro 1.00 ug 133 rAP-0009-1 VEGF-121 (Human) recombinant proteins AngoiPro 1.00 ug 133 Publication
rAP-0009-10 VEGF-121 (Human) recombinant proteins AngoiPro 10.00 ug 279 rAP-0009-10 VEGF-121 (Human) recombinant proteins AngoiPro 10.00 ug 279 Publication
rAP-0009m-10 VEGF-121 (Mouse) recombinant proteins AngoiPro 10.00 ug 279 rAP-0009m-10 VEGF-121 (Mouse) recombinant proteins AngoiPro 10.00 ug 279 Publication
rAP-0009m-2 VEGF-121 (Mouse) recombinant proteins AngoiPro 2.00 ug 133 rAP-0009m-2 VEGF-121 (Mouse) recombinant proteins AngoiPro 2.00 ug 133 Publication
rAP-0010-10 VEGF-121 (Human) Sf9 recombinant proteins AngoiPro 10.00 ug 279 rAP-0010-10 VEGF-121 (Human) Sf9 recombinant proteins AngoiPro 10.00 ug 279 Publication
rAP-0010-2 VEGF-121 (Human) Sf9 recombinant proteins AngoiPro 2.00 ug 133 rAP-0010-2 VEGF-121 (Human) Sf9 recombinant proteins AngoiPro 2.00 ug 133 Publication
rAP-0011-10 VEGF-C (Human) recombinant proteins AngoiPro 10.00 ug 279 rAP-0011-10 VEGF-C (Human) recombinant proteins AngoiPro 10.00 ug 279 Publication
rAP-0011-2 VEGF-C (Human) recombinant proteins AngoiPro 2.00 ug 133 rAP-0011-2 VEGF-C (Human) recombinant proteins AngoiPro 2.00 ug 133 Publication
rAP-0013-10 VEGF-C 152aa (Rat) recombinant proteins AngoiPro 10.00 ug 279 rAP-0013-10 VEGF-C 152aa (Rat) recombinant proteins AngoiPro 10.00 ug 279 Publication
rAP-0013-2 VEGF-C 152aa (Rat) recombinant proteins AngoiPro 2.00 ug 133 rAP-0013-2 VEGF-C 152aa (Rat) recombinant proteins AngoiPro 2.00 ug 133 Publication
rAP-0014-10 VEGF-I (Human) recombinant proteins AngoiPro 10.00 ug 279 rAP-0014-10 VEGF-I (Human) recombinant proteins AngoiPro 10.00 ug 279
ASK
Publication
rAP-0014-2 VEGF-I (Human) recombinant proteins AngoiPro 2.00 ug 133 rAP-0014-2 VEGF-I (Human) recombinant proteins AngoiPro 2.00 ug 133
ASK
Publication
rAP-0015-10 VEGF-E (Orf Virus) recombinant proteins AngoiPro 10.00 ug 279 rAP-0015-10 VEGF-E (Orf Virus) recombinant proteins AngoiPro 10.00 ug 279 Publication
rAP-0015-2 VEGF-E (Orf Virus) recombinant proteins AngoiPro 2.00 ug 133 rAP-0015-2 VEGF-E (Orf Virus) recombinant proteins AngoiPro 2.00 ug 133 Publication
RBMS2019R ELISA Human , VEGF-R2 KDR Biovendor 96 wells (1 kit) 528 RBMS2019R ELISA Human , VEGF-R2 KDR Biovendor 96 wells (1 kit) 528 Publication
RBMS2064R ELISA Human , VEGF-R3 FLT-4 Biovendor 96 wells (1 kit) 528 RBMS2064R ELISA Human , VEGF-R3 FLT-4 Biovendor 96 wells (1 kit) 528 Publication
101-M56 Anti Human, mab VEGF A ( 3C5) Source Mouse Reliatech 100 µg 258 101-M56 Anti Human, mab VEGF A ( 3C5) Source Mouse Reliatech 100 µg 258 Publication
101-M58 Anti Human, mab VEGF A ( 7G7) Source Mouse Reliatech 100 µg 258 101-M58 Anti Human, mab VEGF A ( 7G7) Source Mouse Reliatech 100 µg 258 Publication
101-M59 Anti Human, mab VEGF A ( 3(6D3)) Source Mouse Reliatech 200 µg 243 101-M59 Anti Human, mab VEGF A ( 3(6D3)) Source Mouse Reliatech 200 µg 243 Publication
130-10059-200 Mouse Anti-Human VEGF Antibodies Ray Biotech 200 211 130-10059-200 Mouse Anti-Human VEGF Antibodies Ray Biotech 200 211 Publication
228-10481-1 Recombinant Human FLT1 VEGF R1 Proteins Ray Biotech 2 147 228-10481-1 Recombinant Human FLT1 VEGF R1 Proteins Ray Biotech 2 147 Publication
228-10481-2 Recombinant Human FLT1 VEGF R1 Proteins Ray Biotech 10 205 228-10481-2 Recombinant Human FLT1 VEGF R1 Proteins Ray Biotech 10 205 Publication
228-10481-3 Recombinant Human FLT1 VEGF R1 Proteins Ray Biotech 100 1031 228-10481-3 Recombinant Human FLT1 VEGF R1 Proteins Ray Biotech 100 1031 Publication
228-10482-1 Recombinant Human FLT1 VEGF R1 D3 Proteins Ray Biotech 2 147 228-10482-1 Recombinant Human FLT1 VEGF R1 D3 Proteins Ray Biotech 2 147 Publication
228-10482-2 Recombinant Human FLT1 VEGF R1 D3 Proteins Ray Biotech 10 205 228-10482-2 Recombinant Human FLT1 VEGF R1 D3 Proteins Ray Biotech 10 205 Publication
228-10482-3 Recombinant Human FLT1 VEGF R1 D3 Proteins Ray Biotech 100 1031 228-10482-3 Recombinant Human FLT1 VEGF R1 D3 Proteins Ray Biotech 100 1031 Publication
228-10483-1 Recombinant Human FLT1 VEGF R1 D3 Proteins Ray Biotech 2 147 228-10483-1 Recombinant Human FLT1 VEGF R1 D3 Proteins Ray Biotech 2 147 Publication
228-10483-2 Recombinant Human FLT1 VEGF R1 D3 Proteins Ray Biotech 10 205 228-10483-2 Recombinant Human FLT1 VEGF R1 D3 Proteins Ray Biotech 10 205 Publication
228-10484-1 Recombinant Human FLT1 VEGF R1 D4 Proteins Ray Biotech 2 147 228-10484-1 Recombinant Human FLT1 VEGF R1 D4 Proteins Ray Biotech 2 147 Publication
228-10484-3 Recombinant Human FLT1 VEGF R1 D4 Proteins Ray Biotech 100 1031 228-10484-3 Recombinant Human FLT1 VEGF R1 D4 Proteins Ray Biotech 100 1031 Publication
228-10485-1 Recombinant Human FLT1 VEGF R1 D5 Proteins Ray Biotech 2 147 228-10485-1 Recombinant Human FLT1 VEGF R1 D5 Proteins Ray Biotech 2 147 Publication
228-10485-2 Recombinant Human FLT1 VEGF R1 D5 Proteins Ray Biotech 10 205 228-10485-2 Recombinant Human FLT1 VEGF R1 D5 Proteins Ray Biotech 10 205 Publication
228-10485-3 Recombinant Human FLT1 VEGF R1 D5 Proteins Ray Biotech 100 1031 228-10485-3 Recombinant Human FLT1 VEGF R1 D5 Proteins Ray Biotech 100 1031 Publication
228-10486-1 Recombinant Human FLT1 VEGF R1 D7 Proteins Ray Biotech 2 147 228-10486-1 Recombinant Human FLT1 VEGF R1 D7 Proteins Ray Biotech 2 147 Publication
228-10486-2 Recombinant Human FLT1 VEGF R1 D7 Proteins Ray Biotech 10 205 228-10486-2 Recombinant Human FLT1 VEGF R1 D7 Proteins Ray Biotech 10 205 Publication
228-10486-3 Recombinant Human FLT1 VEGF R1 D7 Proteins Ray Biotech 1mg 0 228-10486-3 Recombinant Human FLT1 VEGF R1 D7 Proteins Ray Biotech 1mg 0 Publication
228-10490-1 Recombinant Human FLT4 VEGF R3 Proteins Ray Biotech 2 147 228-10490-1 Recombinant Human FLT4 VEGF R3 Proteins Ray Biotech 2 147 Publication
228-10490-2 Recombinant Human FLT4 VEGF R3 Proteins Ray Biotech 10 205 228-10490-2 Recombinant Human FLT4 VEGF R3 Proteins Ray Biotech 10 205 Publication
228-10490-3 Recombinant Human FLT4 VEGF R3 Proteins Ray Biotech 1mg 0 228-10490-3 Recombinant Human FLT4 VEGF R3 Proteins Ray Biotech 1mg 0 Publication
228-10491-1 Recombinant Human FLT4 VEGF R3 Fc Proteins Ray Biotech 2 205 228-10491-1 Recombinant Human FLT4 VEGF R3 Fc Proteins Ray Biotech 2 205
ASK
Publication
228-10491-2 Recombinant Human FLT4 VEGF R3 Fc Proteins Ray Biotech 10 292 228-10491-2 Recombinant Human FLT4 VEGF R3 Fc Proteins Ray Biotech 10 292
ASK
Publication
228-10491-3 Recombinant Human FLT4 VEGF R3 Fc Proteins Ray Biotech 1mg 0 228-10491-3 Recombinant Human FLT4 VEGF R3 Fc Proteins Ray Biotech 1mg 0
ASK
Publication
228-11614-1 Recombinant Mouse VEGF VEGFA Proteins Ray Biotech 2 147 228-11614-1 Recombinant Mo